A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)
NCT01469715
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE:
GBP CGM
Sponsor
University of Virginia
Collaborators
[object Object]
[object Object]